We haveenough cashto go wellinto 2023I/ONTAKis our leadassetMino-Lokpotentialmarket>$1BWe willhaveexclusivityWe intendto submita BLA in2H 2022We had aphase 2btrial with100%efficacyHemorrhoidsis a $2BmarketI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Myron Holubiakand I founded aprivatecompany in2013I/ONTAKwas thebest deal Iever madeI/ONTAK'spotentialmarket is>$300mI'm ashareholdermyselfAnymentionof Mino-WrapMino-Lokis our leadassetThere are noFDAapproveddrugs to treathemorrhoidsAn actualiMSCupdateInsidersinvested$26.5mOnly biotechwith 2 Myron'son theleadershipteamOur Halo-Lido trial willhave finalpatient byend of 2022Not manycompaniesthis size with2 late stageassetsWe will openupinternationalsites forMino-Lok trialWe expect tofinish theMino-Loktrial this yearI won't diluteshareholdersWe haveenough cashto go wellinto 2023I/ONTAKis our leadassetMino-Lokpotentialmarket>$1BWe willhaveexclusivityWe intendto submita BLA in2H 2022We had aphase 2btrial with100%efficacyHemorrhoidsis a $2BmarketI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Myron Holubiakand I founded aprivatecompany in2013I/ONTAKwas thebest deal Iever madeI/ONTAK'spotentialmarket is>$300mI'm ashareholdermyselfAnymentionof Mino-WrapMino-Lokis our leadassetThere are noFDAapproveddrugs to treathemorrhoidsAn actualiMSCupdateInsidersinvested$26.5mOnly biotechwith 2 Myron'son theleadershipteamOur Halo-Lido trial willhave finalpatient byend of 2022Not manycompaniesthis size with2 late stageassetsWe will openupinternationalsites forMino-Lok trialWe expect tofinish theMino-Loktrial this yearI won't diluteshareholders

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. We have enough cash to go well into 2023
  2. I/ONTAK is our lead asset
  3. Mino-Lok potential market >$1B
  4. We will have exclusivity
  5. We intend to submit a BLA in 2H 2022
  6. We had a phase 2b trial with 100% efficacy
  7. Hemorrhoids is a $2B market
  8. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  9. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  10. Myron Holubiak and I founded a private company in 2013
  11. I/ONTAK was the best deal I ever made
  12. I/ONTAK's potential market is >$300m
  13. I'm a shareholder myself
  14. Any mention of Mino-Wrap
  15. Mino-Lok is our lead asset
  16. There are no FDA approved drugs to treat hemorrhoids
  17. An actual iMSC update
  18. Insiders invested $26.5m
  19. Only biotech with 2 Myron's on the leadership team
  20. Our Halo-Lido trial will have final patient by end of 2022
  21. Not many companies this size with 2 late stage assets
  22. We will open up international sites for Mino-Lok trial
  23. We expect to finish the Mino-Lok trial this year
  24. I won't dilute shareholders